TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 2 | 1 | 6 | 5 | 11 | 7 | 16 | 17 | 30 | 14 |
P | %wins | 100 | 83 | 83 | 83 | 60 | 60 | 78 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/7/17 15:58 | 2/6/17 | INVH | Invitation Homes Inc. | TX | RlEst | RlEst | Real Estate Operators (No Dev | Gordon G Irwin | TX | O | EVP,CRO | P | 200 | 20.00 | 33 | 10 | 10 | 111 | D | 4 | 0 | 1 | 4 | 3 | |||||||||
2/25/10 16:44 | 2/24/10 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Gordon G Irwin | CO | D | P | 7 | 0.6998 | 0 | 10 | 37 | 37 | D | -61 | 192 | 71 | 75 | 0 | 13 | 0 | 9 | 3 | 27 | 20 | -11 | -36 | -20 | |
11/29/06 16:13 | 11/27/06 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Gordon G Irwin | CO | D | P | 17 | 1.75 | 0 | 10 | 59 | 27 | D | 40 | 40 | 46 | -2 | -4 | -6 | -4 | -6 | 8 | 7 | 12 | 4 | 37 | 28 | |
10/31/05 15:01 | 10/28/05 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Gordon G Irwin | CO | D | P | 2 | 1.03 | 0 | 2 | 13 | 17 | D | -50 | -36 | 80 | 29 | 42 | 12 | -11 | -5 | 11 | 29 | 20 | 39 | 9 | 75 | |
8/25/05 15:37 | 8/24/05 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Gordon G Irwin | CO | D | P | 7 | 0.7451 | 0 | 10 | 200 | 15 | D | -50 | -51 | -39 | -4 | 0 | -5 | -4 | -9 | 4 | 4 | 6 | 58 | 96 | 115 | |
6/1/04 16:16 | 5/28/04 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Gordon G Irwin | CO | D | P.m | 7 | 1.49 | 0 | 5 | New | 5 | D | 104 | 4 | -54 | -48 | -28 | -14 | -11 | -3 | 5 | -1 | -18 | 0 | -23 | -49 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |